greeksoup/ stock research

Easterly Government Properties, Inc.: Q4 FY2025 earnings call

What management said about Q4 FY2025, from the documents filed with the SEC on 23 February 2026: press release. Guidance figures: 6 kept. The quarter’s numbers.

Key takeaways

  • Full-year Core FFO reached $2.99: Full-year 2025 Core FFO was $140.1 million, or $2.99 per share fully diluted, against $126.9 million and $2.91 in 2024. Full-year net income was $13.6 million, or $0.29 per share. Source
  • Richmond campus bought in January: The 297,713 leased square foot campus is leased primarily to the Commonwealth of Virginia, with lease expirations ranging from 2027 to 2036. Source
  • FDA laboratory in Atlanta completed: The 162,000 leased square foot FDA laboratory in Atlanta was substantially completed on December 15, 2025, and revenue commenced with the GSA. Source
  • Renewals and extensions in 2025: The company renewed 104,986 leased square feet for a weighted average lease term of 9.3 years, and extended 197,850 leased square feet for 4.0 years, over full-year 2025. Source
  • Total debt about $1.7 billion: Total indebtedness was about $1.7 billion at year end, including $199.1 million on the revolver, $1.0 billion of senior unsecured notes and $151.7 million of mortgage debt, against about $1.6 billion at September 30. Source
  • Net debt to enterprise value rose: Net Debt to total enterprise value was 61.9%, against 59.9% at September 30. Adjusted Net Debt to annualized quarterly pro forma EBITDA was 7.0x, against 7.2x. Source
  • Q4 dividend of $0.45 declared: The board approved a cash dividend of $0.45 per common share for Q4 2025 on February 18, 2026, payable March 19, 2026. Source

“This year reflects our continued ability to execute on the strategy we've clearly laid out,”

Darrell Crate, President & CEO

Guidance

AreaPeriodFigureAgainst last quarter
Core FFO per share (fully diluted) Sourcefull-year 2026$3.05 - $3.12Kept
Net income per share (fully diluted) Sourcefull-year 2026$0.35 - $0.42Kept
FFO per share (fully diluted) Sourcefull-year 2026$3.03 - $3.10Kept
Real estate depreciation and amortization per share Sourcefull-year 2026$2.68Kept
Wholly owned acquisitions Source2026approximately $50 millionKept
Gross development-related investment Source2026$50 - $100 millionKept

What changed from last quarter

  • Ended: The full-year 2025 Core FFO range of $2.98 to $3.02 is no longer presented; full-year 2025 Core FFO was reported at $2.99 per share.
  • New: A three-asset campus near Richmond, Virginia was acquired on January 16, 2026, after the third quarter. Source
  • Ended: The FDA - Atlanta development was completed, reducing the number of wholly owned properties in development from four to three. Source

Results and growth drivers

  • Fourth quarter net income and Core FFO: Q4 net income was $4.8 million, or $0.10 per share fully diluted, against $5.7 million in Q4 2024. Core FFO was $36.8 million, or $0.77 per share, against $32.6 million and $0.73. Source
  • Full-year Core FFO reached $2.99: Full-year 2025 Core FFO was $140.1 million, or $2.99 per share fully diluted, against $126.9 million and $2.91 in 2024. Full-year net income was $13.6 million, or $0.29 per share. Source
  • Revenue rose on rental income: Q4 total revenues were $87.0 million, against $78.3 million, and rental income was $83.5 million, against $74.1 million. Full-year total revenues were $336.1 million, against $302.1 million. Source
  • Depreciation and amortization increased: Depreciation and amortization was $29.6 million in Q4, against $24.7 million a year earlier. Full-year depreciation and amortization was $113.9 million, against $96.3 million. Source

Acquisitions and developments

  • Three properties bought in 2025: Three properties were acquired in 2025 for an aggregate contractual price of $169.9 million: a 289,873 square foot DC Government facility, DHS - Burlington, and York - Greenwood. Source
  • Richmond campus bought in January: The 297,713 leased square foot campus is leased primarily to the Commonwealth of Virginia, with lease expirations ranging from 2027 to 2036. Source
  • FDA laboratory in Atlanta completed: The 162,000 leased square foot FDA laboratory in Atlanta was substantially completed on December 15, 2025, and revenue commenced with the GSA. Source
  • Flagstaff and Fort Myers under construction: Flagstaff, Arizona is under construction for a 20-year GSA lease for the Judiciary. Fort Myers, Florida is under construction for a 25-year lease with the Florida Department of Law Enforcement. Source
  • Development pipeline of three properties: Three properties were in development at year end, expected to total about 0.2 million rentable square feet, against four properties and 0.3 million square feet at September 30, 2025. Source
  • ICE - Otay sold: The company completed the disposition of ICE - Otay in 2025 for net sale proceeds of about $3.5 million. Source

“By staying disciplined and focused, we are delivering consistent, compounding growth year over year while strengthening our position as a long-term partner to the U.S. Government.”

Darrell Crate, President & CEO

Leasing and tenants

  • Renewals and extensions in 2025: The company renewed 104,986 leased square feet for a weighted average lease term of 9.3 years, and extended 197,850 leased square feet for 4.0 years, over full-year 2025. Source
  • Portfolio size and lease term: The portfolio had 93 operating properties leased primarily to U.S. Government agencies, and a weighted average remaining lease term of 9.5 years and average age of 16.4 years. Source

Costs and interest expense

  • Property and tax costs rose: Q4 property operating expense was $19.8 million, against $18.7 million, and real estate taxes were $8.7 million, against $6.9 million. Corporate G&A was $7.2 million, against $6.4 million. Source
  • Interest expense rose: Net interest expense was $18.1 million in Q4, against $17.2 million, and $74.5 million for full-year 2025, against $62.4 million. Source
  • Impairment loss recorded in 2025: Full-year 2025 included a $2.5 million impairment loss, recorded in the third quarter. No impairment loss appears in Q4 2025. Source

Balance sheet and debt

  • Total debt about $1.7 billion: Total indebtedness was about $1.7 billion at year end, including $199.1 million on the revolver, $1.0 billion of senior unsecured notes and $151.7 million of mortgage debt, against about $1.6 billion at September 30. Source
  • Net debt to enterprise value rose: Net Debt to total enterprise value was 61.9%, against 59.9% at September 30. Adjusted Net Debt to annualized quarterly pro forma EBITDA was 7.0x, against 7.2x. Source
  • Debt maturity and rate shifted: Weighted average debt maturity was 4.2 years and weighted average interest rate was 4.6%, against 4.4 years and 4.7% at September 30. Source
  • $125 million notes issued in March: In March 2025 the company sold $125.0 million of notes in two tranches: $25.0 million at 6.13% due 2030 and $100.0 million at 6.33% due 2032. Source
  • 2018 term loan upsized and extended: The 2018 term loan was upsized from $174.5 million to $200.0 million and extended to August 21, 2028, with extension options to 2030. The 2016 term loan extends to January 28, 2028. Source
  • KBRA rating reaffirmed: KBRA reaffirmed the company's investment grade issuer credit rating of BBB, with a stable designation. Source

Capital, cash and dividend

  • ATM equity raised about $63 million: The company issued 2,466,987 shares under its $300.0 million ATM program. Shares outstanding were 46,303,469 at year end, against 46,108,379 at September 30. Source
  • Cash available for distribution rose: CAD was $29.1 million in Q4, against $25.1 million, and $118.8 million for full-year 2025, against $100.9 million. Source
  • Q4 dividend of $0.45 declared: The board approved a cash dividend of $0.45 per common share for Q4 2025 on February 18, 2026, payable March 19, 2026. Source
  • Maintenance capital spending rose: Maintenance capital expenditures were $6.1 million in Q4, against $5.5 million, and contractual tenant improvements were $1.0 million, against $0.4 million. Source

Coming up, as management said on 23 February 2026

  • Medford courthouse delivery in 2027: Medford courthouse sitework began in Q4 2025, with delivery expected in the second half of 2027, after which a 20-year GSA lease for the Judiciary commences. Source
  • Fort Myers laboratory delivery in 2026: Fort Myers sitework began in Q3 2025, with delivery expected in the second half of 2026, after which a 25-year firm term lease with the State of Florida commences. Source

Figures management reported

FigureReported
Core FFO per share, fully diluted (full year 2025) Source$2.99
FFO per share, fully diluted (full year 2025) Source$2.95
Acquisitions (full year 2025) Source$169.9 million, three properties
Dispositions (full year 2025) SourceICE - Otay, about $3.5 million net sale proceeds
Net Debt to total enterprise value Source61.9%
Adjusted Net Debt to annualized quarterly pro forma EBITDA Source7.0x
Leased square feet extended (full year 2025) Source197,850 sq ft, 4.0-year weighted average term

Earlier plans management reported on

  • Not stated: Management said it is maintaining the 2026 Core FFO range, which was first issued in the third quarter release. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.